A series of peptides patterned on the principal neutralizing domain of the HIV-1 envelope glycoprotein gp 120 have been synthesized by solid-phase techniques. Interestingly, in vitro experiments have shown that some of these peptides specifically interact with CD4 and, in particular, that the peptid
Biological and conformational studies on analogues of a synthetic peptide enhancing HIV-1 infection
β Scribed by Monica Dettin; Claudia Scarinci; Carlo Zanotto; Rossella Roncon; Anita De Rossi; Carlo Di Bello
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 153 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1075-2617
No coin nor oath required. For personal study only.
β¦ Synopsis
We have previously demonstrated that a 23-amino acid peptide derived from the V3 loop of the surface glycoprotein of the HIV-1 strain MN is able to bind CD4 and to enhance HIV-1 infection. Further studies have suggested that the peptide/CD4 interaction induces an increase in both CD4 expression and CD4/gp120 binding affinity. This paper describes the biological and physico-chemical characterization of three analogues of reduced sequence that have been designed in order to identify the minimum active sequence of this peptide corresponding to the MN-HIV- 1 principal neutralizing domain. Biological studies indicate that the entire sequence is required for biological activity and that the sequence 1-18 presents an inhibitory activity. CD and FT-IR absorption data are discussed here in order to identify possible structure-function correlations.
π SIMILAR VOLUMES
For some membrane-associated antigens, the number of molecules expressed per cell carries information about the cell's differentiation and activation state. Quantitating antigen expression by flow cytometry has immediate application in monitoring CD38 expression on CD8 Ψ T cells in human immunodefic